OBJECTIVE: To evaluate the biological behavior of noninvasive papillary serous carcinoma
of the endometrium. METHODS: From 1990 to 2001, all women with noninvasive uterine …

As a disease entity, uterine papillary serous carcinoma (UPSC) is a relative newcomer. It
was first identified as a distinct histologic entity in 1981 by Lauchlan [1]. The subsequent …

In recent years, it has become apparent that most patients with endometrial carcinoma
possess one of two relatively distinctive clinicopathological syndromes [1]. Type I: The …

Endometrial serous carcinomas (ESC) constitute only approximately 10% of endometrial
cancers, but have a substantially higher case-fatality rate than their more common …

Objective Uterine serous carcinoma (USC) is an aggressive type 2 endometrial cancer. Data
on prognostic factors for patients with early-stage USC without adjuvant therapy are limited …

Serous endometrial cancer represents a relative rare entity accounting for about 10% of all
diagnosed endometrial cancer, but it is responsible for 40% of endometrial cancer-related …

OBJECTIVE: Uterine papillary serous carcinoma (UPSC) represents a distinct subtype of
endometrial cancer. UPSC is less common than endometrioid carcinoma (ECC) but …

Background. Uterine papillary serous carcinoma (UPSC) is a histologic subtype of
endometrial adenocarcinoma that is characterized by its papillary architecture, poor …

Objective The aim of this study was to investigate the clinicopathologic features and the
outcome in patients with pure and mixed type uterine papillary serous carcinoma (UPSC) …

The incidence and mortality rates from endometrial cancer continue to increase worldwide,
while rates in most other cancers have either plateaued or declined considerably. Uterine …